Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Mata

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Journal of Clinical Lipidology|May 14, 2018
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART studyLeopoldo Pérez de Isla, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, et al.
Journal of Clinical Lipidology|November 11, 2019
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART studyLeopoldo Pérez de Isla, Raquel Arroyo-Olivares, Ovidio Muñiz-Grijalvo, et al.
The Lancet. Diabetes & Endocrinology|August 4, 2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort studyLeopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 8, 2020
Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in IberoamericaAna Catarina Alves, Rodrigo Alonso, José Luís Diaz-Diaz, et al.
Journal of the American College of Cardiology|January 20, 2018
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular OutcomesLaura D'Erasmo, Ilenia Minicocci, Antonio Nicolucci, et al.
Revista Espanola De Cardiologia (English Ed.)|March 24, 2020
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registryLeopoldo Pérez de Isla, Raquel Arroyo-Olivares, Rodrigo Alonso, et al.
Journal of the American College of Cardiology|August 4, 2018
Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert PanelAmy C Sturm, Joshua W Knowles, Samuel S Gidding, et al.
Revista Espanola De Cardiologia (English Ed.)|January 30, 2017
Comments on the 2016 ESC/EAS Guidelines for the Management of DyslipidemiasL Pérez de Isla, , Leopoldo Pérez de Isla, et al.
Atherosclerosis|September 27, 2015
Familial hypercholesterolaemia: A global call to armsAntonio J Vallejo-Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole, et al.
Atherosclerosis. Supplements|December 13, 2016
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration, Antonio J Vallejo-Vaz, Asif Akram, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Lipidology|May 14, 2018
Coronary computed tomographic angiography findings and their therapeutic implications in asymptomatic patients with familial hypercholesterolemia. Lessons from the SAFEHEART studyLeopoldo Pérez de Isla, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, et al.
Journal of Clinical Lipidology|November 11, 2019
Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART studyLeopoldo Pérez de Isla, Raquel Arroyo-Olivares, Ovidio Muñiz-Grijalvo, et al.
The Lancet. Diabetes & Endocrinology|August 4, 2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort studyLeopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 8, 2020
Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in IberoamericaAna Catarina Alves, Rodrigo Alonso, José Luís Diaz-Diaz, et al.
Journal of the American College of Cardiology|January 20, 2018
Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular OutcomesLaura D'Erasmo, Ilenia Minicocci, Antonio Nicolucci, et al.
Revista Espanola De Cardiologia (English Ed.)|March 24, 2020
Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registryLeopoldo Pérez de Isla, Raquel Arroyo-Olivares, Rodrigo Alonso, et al.
Journal of the American College of Cardiology|August 4, 2018
Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert PanelAmy C Sturm, Joshua W Knowles, Samuel S Gidding, et al.
Revista Espanola De Cardiologia (English Ed.)|January 30, 2017
Comments on the 2016 ESC/EAS Guidelines for the Management of DyslipidemiasL Pérez de Isla, , Leopoldo Pérez de Isla, et al.
Atherosclerosis|September 27, 2015
Familial hypercholesterolaemia: A global call to armsAntonio J Vallejo-Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole, et al.
Atherosclerosis. Supplements|December 13, 2016
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration, Antonio J Vallejo-Vaz, Asif Akram, et al.
Pageof 15